Information från ABG Sundal Collier

Här finner du information kring börsens mindre och medelstora bolag. Avsändare är ABG Sundal Collier, innehållet är inte skapat av placera.nu:s redaktion.

« Tillbaka

SinterCast - Past the trough, but recovery pace uncertain

19 augusti 2026

<a id="bm-comp-513880b7-7024-4dca-b70d-a55db123a629" name="bm-comp-513880b7-7024-4dca-b70d-a55db123a629" class="BMCustomAnchor"></a><table><tr><td bm-component-id="513880b7-7024-4dca-b70d-a55db123a629" style="vertical-align: top; width:100.000000%;"><ul><li>Sales 1% above us, but EBIT 10% below on a softer gross margin</li><li>Past the H2'25 trough, larger volume ramp to start in Q4'26</li><li>We cut '26e-'28e EBIT by 9-4% on ramp timing and FX</li></ul></td></tr></table><a id="bm-comp-ab6f6fb8-84d5-412e-afdf-d176287ebf70" name="bm-comp-ab6f6fb8-84d5-412e-afdf-d176287ebf70" class="BMCustomAnchor"></a><table><tr><td bm-component-id="ab6f6fb8-84d5-412e-afdf-d176287ebf70" style="vertical-align: top; width:100.000000%;"><h3 class="bm-h3">Q2 results</h3><p>Q2 sales were 1% above ABGSCe while EBIT was 10% below, at SEK 27.4m (31.1m) and SEK 7.4m (11.2m), respectively. Volumes were pre-announced in July's H1 update, although Q2 Engine Equivalents of 3.1m (3.4m) were slightly below the 3.2m implied there, likely due to rounding. Unusually high engineering service revenue of SEK 1.0 million (0.3 million) drove the sales beat. The EBIT margin of 27.1% (36.1%) was 3pp below our estimate on a gross margin of 69.4% (71.4%) against our 72.0%. We view this as a quarterly fluctuation in a lower-volume environment rather than something to extrapolate. Despite still constituting a negative y-o-y development, the recovery from the H2'25 trough was confirmed.</p><h3 class="bm-h3">Estimate changes</h3><p>We cut '26e/'27e/'28e EBIT by 9%/7%/4%, as we have pushed back the EE ramp somewhat based on management comments that higher production volumes are expected towards the end of H2'26 due to the recovery of the commercial vehicle sector and the ramp-up of new programmes. We now forecast EEs of 3.2m/3.8m in '26e/'27e, with '28e essentially unchanged at 4.5m. Updated FX takes a further ~2% off '27e-'28e sales.</p><h3 class="bm-h3">Outlook and valuation</h3><p>The expected recovery looks broadly intact to us: H1 EEs were 15% above H2'25, and the company points to global commercial vehicle orders up ~30% y-o-y and ~140% in North America on fleet renewal and the EPA 2027 pre-buy. Further evidence of an increase in volume comes from the new production programmes, some of which are already ramping up with more starting between '27 and '30. These programmes underpin the company's 6m ('29) and 8m ('31) EE milestones. We lower our fair value range to SEK 90-120 (95-125) on our reduced estimates. The share is trading at 26x/15x '26e/'28e P/E vs. its historical median of 22x/14x.</p></td></tr></table>

Senaste artiklar från alla bolag

Datum Titel Bolag Typ
2026-09-06 Petrolia Noco - Brage shutdown masked by price an... Petrolia Noco Analys
2026-09-04 Nepa - Marketing measurement on a recurring base Nepa Analys
2026-09-02 Qben Infra - Needs more time to convert growth to... Qben Infra Analys
2026-09-02 Xplora Technologies - A setback, but long-term po... Xplora Tech.. Analys
2026-09-02 Proact - Dell Q2: Storage sales +12% vs cons Proact Analys
2026-08-28 Gentoo Media - Deleveraging focus in H2'26 Gentoo Media Analys
2026-08-27 Lumi Gruppen - Margins strong, but softer intake ... Lumi Gruppen Analys
2026-08-27 Lumi Gruppen - Delivering on H1, H2 looks more ch... Lumi Gruppen Analys
2026-08-26 Inission - Power turnaround progressing well Inission Analys
2026-08-26 Gentoo Media - A bit softer than expected Gentoo Media Analys
2026-08-26 Inission - Inission Power drives beat, demand sti... Inission Analys
2026-08-25 Isofol Medical - Maximising the dose before Phase 2 Isofol Medical Analys
2026-08-24 Skolon - Broad-based growth continues Skolon Analys
2026-08-24 Gentoo Media - FCF generation remains top priority Gentoo Media Analys
2026-08-24 Impact Coatings - Backlog to carry H2e Impact Coat.. Analys
2026-08-24 I-tech - Beyond a single molecule I-tech Analys
2026-08-23 Catella - Signs of improvement, but delivery stil... Catella Analys
2026-08-23 Ogunsen - Some signs of stabilisation Ogunsen Analys
2026-08-21 Clavister - Strong quarter strengthens the outlook Clavister Analys
2026-08-21 Generic - Investing while growing Generic Analys